APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preterm Birth Prevention and Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Preterm Birth Prevention and Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17402838032 January 2026199 pages

Choose your research edition.

Industry ResearchPreterm Birth Prevention and Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Preterm Birth Prevention and Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Preterm Birth Prevention and Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preterm Birth Prevention and Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Preterm Birth Prevention and Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Preterm Birth Prevention and Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Preterm Birth Prevention and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preterm Birth Prevention and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preterm Birth Prevention and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Preterm Birth Prevention and Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preterm Birth Prevention and Treatment include Teva, Sanofi, Novartis, Merck & Co, Pfizer, Bayer, AbbVie, Viatris and Ferring Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Preterm Birth Prevention and Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preterm Birth Prevention and Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preterm Birth Prevention and Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Preterm Birth Prevention and Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Preterm Birth Prevention and Treatment Segment by Company

Teva

Sanofi

Novartis

Merck & Co

Pfizer

Bayer

AbbVie

Viatris

Ferring Pharmaceutical

Aurobindo Pharma

AMAG Pharmaceuticals

Allergan

Preterm Birth Prevention and Treatment Segment by Type

Progesterone Therapy

Tocolytics Therapy

Corticosteroid Therapy

Magnesium Sulfate Therapy

Antihypertensive Therapy

Other

Preterm Birth Prevention and Treatment Segment by Application

Hospital

Drugs Stores

Other

Preterm Birth Prevention and Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Preterm Birth Prevention and Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preterm Birth Prevention and Treatment industry.

Chapter 3: Detailed analysis of Preterm Birth Prevention and Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preterm Birth Prevention and Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Progesterone Therapy Table 3. Key Players of Tocolytics Therapy Table 4. Key Players of Corticosteroid Therapy Table 3. Key Players of Magnesium Sulfate Therapy Table 4. Key Players of Antihypertensive Therapy Table 5. Key Players of Other Table 6. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospital Table 8. Key Players of Drugs Stores Table 9. Key Players of Other Table 10. Global Preterm Birth Prevention and Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Preterm Birth Prevention and Treatment Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Preterm Birth Prevention and Treatment Market Share by Region (2021-2026) Table 13. Global Preterm Birth Prevention and Treatment Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Preterm Birth Prevention and Treatment Market Share by Region (2027-2032) Table 15. Preterm Birth Prevention and Treatment Industry Trends Table 16. Preterm Birth Prevention and Treatment Industry Drivers Table 17. Preterm Birth Prevention and Treatment Industry Opportunities and Challenges Table 18. Preterm Birth Prevention and Treatment Industry Restraints Table 19. Global Preterm Birth Prevention and Treatment Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Preterm Birth Prevention and Treatment Revenue Market Share by Company (2021-2026) Table 21. Global Preterm Birth Prevention and Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Preterm Birth Prevention and Treatment Key Company Head Office and Area Served Table 23. Global Preterm Birth Prevention and Treatment Company, Product Type & Application Table 24. Global Preterm Birth Prevention and Treatment Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Preterm Birth Prevention and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Preterm Birth Prevention and Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2027-2032) Table 32. Global Preterm Birth Prevention and Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021-2026) Table 36. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2027-2032) Table 37. Teva Company Information Table 38. Teva Business Overview Table 39. Teva Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Teva Preterm Birth Prevention and Treatment Product Portfolio Table 41. Teva Recent Development Table 42. Sanofi Company Information Table 43. Sanofi Business Overview Table 44. Sanofi Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Sanofi Preterm Birth Prevention and Treatment Product Portfolio Table 46. Sanofi Recent Development Table 47. Novartis Company Information Table 48. Novartis Business Overview Table 49. Novartis Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Novartis Preterm Birth Prevention and Treatment Product Portfolio Table 51. Novartis Recent Development Table 52. Merck & Co Company Information Table 53. Merck & Co Business Overview Table 54. Merck & Co Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Merck & Co Preterm Birth Prevention and Treatment Product Portfolio Table 56. Merck & Co Recent Development Table 57. Pfizer Company Information Table 58. Pfizer Business Overview Table 59. Pfizer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pfizer Preterm Birth Prevention and Treatment Product Portfolio Table 61. Pfizer Recent Development Table 62. Bayer Company Information Table 63. Bayer Business Overview Table 64. Bayer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bayer Preterm Birth Prevention and Treatment Product Portfolio Table 66. Bayer Recent Development Table 67. AbbVie Company Information Table 68. AbbVie Business Overview Table 69. AbbVie Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. AbbVie Preterm Birth Prevention and Treatment Product Portfolio Table 71. AbbVie Recent Development Table 72. Viatris Company Information Table 73. Viatris Business Overview Table 74. Viatris Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Viatris Preterm Birth Prevention and Treatment Product Portfolio Table 76. Viatris Recent Development Table 77. Ferring Pharmaceutical Company Information Table 78. Ferring Pharmaceutical Business Overview Table 79. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product Portfolio Table 81. Ferring Pharmaceutical Recent Development Table 82. Aurobindo Pharma Company Information Table 83. Aurobindo Pharma Business Overview Table 84. Aurobindo Pharma Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Aurobindo Pharma Preterm Birth Prevention and Treatment Product Portfolio Table 86. Aurobindo Pharma Recent Development Table 87. AMAG Pharmaceuticals Company Information Table 88. AMAG Pharmaceuticals Business Overview Table 89. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product Portfolio Table 91. AMAG Pharmaceuticals Recent Development Table 92. Allergan Company Information Table 93. Allergan Business Overview Table 94. Allergan Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Allergan Preterm Birth Prevention and Treatment Product Portfolio Table 96. Allergan Recent Development Table 97. North America Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Preterm Birth Prevention and Treatment Market Size by Country (2021-2026) Table 103. North America Preterm Birth Prevention and Treatment Market Size by Country (2027-2032) Table 104. Europe Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Preterm Birth Prevention and Treatment Market Size by Country (2021-2026) Table 110. Europe Preterm Birth Prevention and Treatment Market Size by Country (2027-2032) Table 111. China Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 112. China Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 113. China Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 114. China Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Preterm Birth Prevention and Treatment Market Size by Country (2021-2026) Table 121. Asia Preterm Birth Prevention and Treatment Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Preterm Birth Prevention and Treatment Product Image Figure 2. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Preterm Birth Prevention and Treatment Market Share by Type: 2025 VS 2032 Figure 4. Progesterone Therapy Image Figure 5. Tocolytics Therapy Image Figure 6. Corticosteroid Therapy Image Figure 7. Magnesium Sulfate Therapy Image Figure 8. Antihypertensive Therapy Image Figure 9. Other Image Figure 10. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Preterm Birth Prevention and Treatment Market Share by Application: 2025 VS 2032 Figure 12. Hospital Image Figure 13. Drugs Stores Image Figure 14. Other Image Figure 15. Global Preterm Birth Prevention and Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 17. Global Preterm Birth Prevention and Treatment Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Preterm Birth Prevention and Treatment Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Preterm Birth Prevention and Treatment Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Preterm Birth Prevention and Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2021-2032) Figure 24. Global Preterm Birth Prevention and Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 27. North America Preterm Birth Prevention and Treatment Market Share by Type (2021-2032) Figure 28. North America Preterm Birth Prevention and Treatment Market Share by Application (2021-2032) Figure 29. North America Preterm Birth Prevention and Treatment Market Share by Country (2021-2032) Figure 30. United States Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Canada Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 34. Europe Preterm Birth Prevention and Treatment Market Share by Type (2021-2032) Figure 35. Europe Preterm Birth Prevention and Treatment Market Share by Application (2021-2032) Figure 36. Europe Preterm Birth Prevention and Treatment Market Share by Country (2021-2032) Figure 37. Germany Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 38. France Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Italy Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Russia Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 44. China Preterm Birth Prevention and Treatment Market Share by Type (2021-2032) Figure 45. China Preterm Birth Prevention and Treatment Market Share by Application (2021-2032) Figure 46. Asia Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 47. Asia Preterm Birth Prevention and Treatment Market Share by Type (2021-2032) Figure 48. Asia Preterm Birth Prevention and Treatment Market Share by Application (2021-2032) Figure 49. Asia Preterm Birth Prevention and Treatment Market Share by Country (2021-2032) Figure 50. Japan Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 54. India Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 55. Australia Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Country (2021-2032) Figure 60. Brazil Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 65. UAE Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Chile Preterm Birth Prevention and Treatment Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Progesterone Therapy
  • Tocolytics Therapy
  • Corticosteroid Therapy
  • Magnesium Sulfate Therapy
  • Antihypertensive Therapy
  • Other
Applications
  • Hospital
  • Drugs Stores
  • Other
Companies covered
  • Teva
  • Sanofi
  • Novartis
  • Merck & Co
  • Pfizer
  • Bayer
  • AbbVie
  • Viatris
  • Ferring Pharmaceutical
  • Aurobindo Pharma
  • AMAG Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Progesterone Therapy
  5. 1.2.3 Tocolytics Therapy
  6. 1.2.4 Corticosteroid Therapy
  7. 1.2.5 Magnesium Sulfate Therapy
  8. 1.2.6 Antihypertensive Therapy
  9. 1.2.7 Other
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Drugs Stores
  14. 1.3.4 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Preterm Birth Prevention and Treatment Growth Trends by Region
  17. 1.5.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Preterm Birth Prevention and Treatment Market Size by Region (2021-2026)
  19. 1.5.3 Preterm Birth Prevention and Treatment Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Preterm Birth Prevention and Treatment Market Dynamics
  1. 2.1 Preterm Birth Prevention and Treatment Industry Trends
  2. 2.2 Preterm Birth Prevention and Treatment Industry Drivers
  3. 2.3 Preterm Birth Prevention and Treatment Industry Opportunities and Challenges
  4. 2.4 Preterm Birth Prevention and Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Preterm Birth Prevention and Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Preterm Birth Prevention and Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Preterm Birth Prevention and Treatment Key Company Head office and Area Served
  4. 3.4 Global Preterm Birth Prevention and Treatment Company, Product Type & Application
  5. 3.5 Global Preterm Birth Prevention and Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Preterm Birth Prevention and Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Preterm Birth Prevention and Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Preterm Birth Prevention and Treatment Tier 1, Tier 2, and Tier 3
4 Preterm Birth Prevention and Treatment Market by Type
  1. 4.1 Global Preterm Birth Prevention and Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Preterm Birth Prevention and Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Preterm Birth Prevention and Treatment Market Size Share by Type (2021-2032)
5 Preterm Birth Prevention and Treatment Market by Application
  1. 5.1 Global Preterm Birth Prevention and Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Preterm Birth Prevention and Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Preterm Birth Prevention and Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Preterm Birth Prevention and Treatment Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Preterm Birth Prevention and Treatment Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Preterm Birth Prevention and Treatment Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck & Co
  20. 6.4.1 Merck & Co Company Information
  21. 6.4.2 Merck & Co Business Overview
  22. 6.4.3 Merck & Co Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck & Co Preterm Birth Prevention and Treatment Product Portfolio
  24. 6.4.5 Merck & Co Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Preterm Birth Prevention and Treatment Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer Preterm Birth Prevention and Treatment Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AbbVie Preterm Birth Prevention and Treatment Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viatris Preterm Birth Prevention and Treatment Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Ferring Pharmaceutical
  50. 6.9.1 Ferring Pharmaceutical Company Information
  51. 6.9.2 Ferring Pharmaceutical Business Overview
  52. 6.9.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product Portfolio
  54. 6.9.5 Ferring Pharmaceutical Recent Developments
  55. 6.10 Aurobindo Pharma
  56. 6.10.1 Aurobindo Pharma Company Information
  57. 6.10.2 Aurobindo Pharma Business Overview
  58. 6.10.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Aurobindo Pharma Preterm Birth Prevention and Treatment Product Portfolio
  60. 6.10.5 Aurobindo Pharma Recent Developments
  61. 6.11 AMAG Pharmaceuticals
  62. 6.11.1 AMAG Pharmaceuticals Company Information
  63. 6.11.2 AMAG Pharmaceuticals Business Overview
  64. 6.11.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product Portfolio
  66. 6.11.5 AMAG Pharmaceuticals Recent Developments
  67. 6.12 Allergan
  68. 6.12.1 Allergan Company Information
  69. 6.12.2 Allergan Business Overview
  70. 6.12.3 Allergan Preterm Birth Prevention and Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Allergan Preterm Birth Prevention and Treatment Product Portfolio
  72. 6.12.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Preterm Birth Prevention and Treatment Market Size (2021-2032)
  2. 7.2 North America Preterm Birth Prevention and Treatment Market Size by Type
  3. 7.2.1 North America Preterm Birth Prevention and Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Preterm Birth Prevention and Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Preterm Birth Prevention and Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Preterm Birth Prevention and Treatment Market Size by Application
  7. 7.3.1 North America Preterm Birth Prevention and Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Preterm Birth Prevention and Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Preterm Birth Prevention and Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Preterm Birth Prevention and Treatment Market Size by Country
  11. 7.4.1 North America Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Preterm Birth Prevention and Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Preterm Birth Prevention and Treatment Market Size (2021-2032)
  2. 8.2 Europe Preterm Birth Prevention and Treatment Market Size by Type
  3. 8.2.1 Europe Preterm Birth Prevention and Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Preterm Birth Prevention and Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Preterm Birth Prevention and Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Preterm Birth Prevention and Treatment Market Size by Application
  7. 8.3.1 Europe Preterm Birth Prevention and Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Preterm Birth Prevention and Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Preterm Birth Prevention and Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Preterm Birth Prevention and Treatment Market Size by Country
  11. 8.4.1 Europe Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Preterm Birth Prevention and Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Preterm Birth Prevention and Treatment Market Size (2021-2032)
  2. 9.2 China Preterm Birth Prevention and Treatment Market Size by Type
  3. 9.2.1 China Preterm Birth Prevention and Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Preterm Birth Prevention and Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Preterm Birth Prevention and Treatment Market Share by Type (2021-2032)
  6. 9.3 China Preterm Birth Prevention and Treatment Market Size by Application
  7. 9.3.1 China Preterm Birth Prevention and Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Preterm Birth Prevention and Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Preterm Birth Prevention and Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Preterm Birth Prevention and Treatment Market Size (2021-2032)
  2. 10.2 Asia Preterm Birth Prevention and Treatment Market Size by Type
  3. 10.2.1 Asia Preterm Birth Prevention and Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Preterm Birth Prevention and Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Preterm Birth Prevention and Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Preterm Birth Prevention and Treatment Market Size by Application
  7. 10.3.1 Asia Preterm Birth Prevention and Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Preterm Birth Prevention and Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Preterm Birth Prevention and Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Preterm Birth Prevention and Treatment Market Size by Country
  11. 10.4.1 Asia Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Preterm Birth Prevention and Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst